Form 8-K Horizon Pharma plc For: Apr 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Horizon Pharma (HZNP) Affirms FY 2016 Net Sales Guidance
April 12, 2016 8:09 AM EDTHorizon Pharma (NASDAQ: HZNP) disclosed in an SEC filing:
On April 12, 2016, Horizon Pharma plc made publicly available an updated investor presentation that contains projections of net sales and adjusted EBITDA for the first quarter ended March 31, 2016, the second quarter 2016, as well as prescription results for certain of Horizon Pharmas medicines during the first quarter of 2016. The presentation is furnished as Exhibit 99.1 hereto, and will also be available on the investor relations section of Horizon Pharmas web... More
Horizon Pharma (HZNP) Offers H116 Net Sales, adj.-EBITDA Outlook; Provides Q1 Prescription Results
April 12, 2016 8:07 AM EDTHorizon Pharma (NASDAQ: HZNP) disclosed the following on Tuesday:
Item 2.02Results of Operations and Financial ConditionOn April 12, 2016, Horizon Pharma plc made publicly available an updated investor presentation that contains projections of net sales and adjusted EBITDA for... More
